Literature DB >> 12046991

Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils.

Nobuyuki Fukuishi1, Motoko Matsuhisa, Takeshi Shimono, Nobutoshi Murata, Mari Iwanaga, Hidenori Sagara, Nobuaki Matsui, Masaaki Akagi.   

Abstract

The inhibitory effect of olopatadine, a new antiallergic drug, on antigen-induced eosinophil infiltration and its mechanisms were examined using the local sensitized rat allergic rhinitis model and isolated IL-5-stimulated rat peritoneal eosinophils. Olopatadine dose-dependently inhibited antigen-induced eosinophil infiltration in the nasal mucosa. Olopatadine dose-dependently repressed the IL-5-induced expressions of CD11a/CD18 (LFA-1) and CD11b/CD18 (Mac-1) on rat peritoneal eosinophils. However, olopatadine had no effect on IL-5-induced CD49d/CD29 (VLA-4) expression. These results suggest that olopatadine may inhibit antigen-induced eosinophil infiltration through repression of LFA-1 and Mac-1 expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046991     DOI: 10.1254/jjp.88.463

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

1.  Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis.

Authors:  Santa J Ono; Keith Lane
Journal:  Drug Des Devel Ther       Date:  2011-02-08       Impact factor: 4.162

2.  Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety.

Authors:  Rituparna Maiti; Jyothirmai Jaida; Jalelur Rahman; Rajasri Gaddam; Anuradha Palani
Journal:  J Pharmacol Pharmacother       Date:  2011-10

3.  Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein.

Authors:  Kazuya Kishimoto; Satoshi Kaneko; Kenji Ohmori; Tadafumi Tamura; Kazuhide Hasegawa
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 4.  Ocular allergy treatment comparisons: azelastine and olopatadine.

Authors:  Leonard Bielory; Praveen Buddiga; Stephen Bigelson
Journal:  Curr Allergy Asthma Rep       Date:  2004-07       Impact factor: 4.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.